Compound Detail
CHEMBL4777713
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL4777713 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | DKSUFAICVVIKOK-UHFFFAOYSA-N |
6
Targets
6
Activities
1
Assay Types
0
PK Parameters
6
Publications
0
Known Names
Molecular Properties
405.5
MW (Da)
5.40
ALogP
3
HBA
2
HBD
45.4
PSA (Ų)
0.39
QED
1
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Unknown |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 6 meas. best 5.63
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| NCI-H460 CHEMBL396 | IC50 | 5.63 | 5.63 | 2340.0 | 1 |
| CCRF-CEM CHEMBL382 | IC50 | 5.49 | 5.49 | 3210.0 | 1 |
| CEM-VLB CHEMBL614554 | IC50 | 5.44 | 5.44 | 3660.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 5.35 | 5.35 | 4450.0 | 1 |
| HCT-116 CHEMBL394 | IC50 | 5.22 | 5.22 | 5990.0 | 1 |
| NCI-H1650 CHEMBL1075518 | IC50 | 5.1 | 5.1 | 7950.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| NCI-H460 | IC50 | = | 2340.0 | nM | 5.63 | Cytotoxicity against human NCI-H460 cells assessed as reduction in cell viabilit... | 32622270 |
| CCRF-CEM | IC50 | = | 3210.0 | nM | 5.49 | Cytotoxicity against human CCRF-CEM cells assessed as reduction in cell viabilit... | 32622270 |
| CEM-VLB | IC50 | = | 3660.0 | nM | 5.44 | Cytotoxicity against human CEM-VLB cells assessed as reduction in cell viability... | 32622270 |
| Unchecked | IC50 | = | 4450.0 | nM | 5.35 | Cytotoxicity against human PacaS1 cells assessed as reduction in cell viability ... | 32622270 |
| HCT-116 | IC50 | = | 5990.0 | nM | 5.22 | Cytotoxicity against human HCT-116 cells assessed as reduction in cell viability... | 32622270 |
| NCI-H1650 | IC50 | = | 7950.0 | nM | 5.1 | Cytotoxicity against human NCI-H1650 cells assessed as reduction in cell viabili... | 32622270 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 32622270 | 10.1016/j.ejmech.2020.112516 | Unchecked | 2 |
| 32622270 | 10.1016/j.ejmech.2020.112516 | CCRF-CEM | 1 |
| 32622270 | 10.1016/j.ejmech.2020.112516 | CEM-VLB | 1 |
| 32622270 | 10.1016/j.ejmech.2020.112516 | HCT-116 | 1 |
| 32622270 | 10.1016/j.ejmech.2020.112516 | NCI-H1650 | 1 |
| 32622270 | 10.1016/j.ejmech.2020.112516 | NCI-H460 | 1 |
Data from ChEMBL 36 via Core Engine